According to Spero Therapeutics's latest financial reports the company's current earnings (TTM) are A$26.3 M. In 2023 the company made an earning of A$35.19 M an increase over its 2022 earnings that were of -A$65.71 M.The earnings displayed on this page is the company's Pretax Income.